Atlas Trials

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years

Clinical trial NCT00761631 · COMPLETED

Trial details

NCT number
NCT00761631
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2008-11-18
Primary completion
2010-08-10
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.